Skip to main content
SpringerLink
Log in

Peripartum cardiomyopathy

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

It is critical that the diagnosis of peripartum cardiomyopathy is limited to women with congestive heart failure and decreased systolic function of the left ventricle in last month of pregnancy or within 5 months after delivery. Patients must have no pre-existing cardiac disease and no other cause for current cardiac dysfunction. The inclusion of patients before the last month of pregnancy or after 5 months postpartum introduces a large number of patients with cardiac disorders due to causes other than peripartum cardiomyopathy. Ventricular performance at rest and with exertion determines the type of management, its intensity, and duration. Patients whose ventricular function is normal at rest and with exercise or dobutamine can have their heart failure therapy tapered and ultimately discontinued after 6 to 12 months of standard treatment. Those with normal resting but abnormal stress cardiac function should continue some form of medical therapy (afterload reduction or beta-blocker) for longer periods of time, if not for life. Those with persistently abnormal ventricular function must receive optimal heart failure therapy forever and face the same relatively poor prognosis as patients with dilated cardiomyopathy from any cause. Options for management include standard heart failure therapy (digoxin, diuretics, afterload reduction, and anticoagulation), Swan-Ganz catheter monitoring and use of inotropic agents, intra-aortic balloon counterpulsation, and left ventricular assist device. Patients with peripartum cardiomyopathy are candidates for heart transplantation, assuming they meet all other criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Felker GM, Hu Weimin, Hare JM, et al.: The spectrum of dilated cardiomyopathy: the Johns Hopkins Experience with 1,278 patients. Medicine 1999, 78:270–283.

    Article  PubMed  CAS  Google Scholar 

  2. Demakis JG, Rahimtoola SH, Sutton GC, et al.: Natural course of peripartum cardiomyopathy. Circulation 1971, 44:1053–1061. This classic article defines the condition and allows a perspective on the natural history.

    PubMed  CAS  Google Scholar 

  3. Pearson GD, Veille JC, Rahimtoola S, et al.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283:1183–1188. This consensus document is an outstanding resource for state-of-the-art knowledge of peripartum cardiomyopathy.

    Article  PubMed  CAS  Google Scholar 

  4. Melvin KR, Richardson PJ, Olsen EG, et al.: Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1992, 307:731–734.

    Article  Google Scholar 

  5. Midei MG, DeMent SH, Feldman AM, et al.: Peripartum myocarditis and cardiomyopathy. Circulation 1990, 81:1154–1156.

    Google Scholar 

  6. Rizeq MN, Rickenbacher PR, Fowler MB, et al.: Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994, 74:474–477.

    Article  PubMed  CAS  Google Scholar 

  7. Chow LH, Radio SJ, Sears TD, et al.: Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989, 14:915–920.

    Article  PubMed  CAS  Google Scholar 

  8. Hauck AJ, Kearney DL, Edwards WD: Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989, 64:1235–1245.

    PubMed  CAS  Google Scholar 

  9. Aretz HT, Billingham ME, Edwards WD, et al.: Myocarditis: a histopathologic definition and classification. Am J Cardiovas Path 1986, 1:3–14.

    Google Scholar 

  10. Felker GM, Jaeger CJ, Klodas E, et al.: Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000, 140:785–791.

    Article  PubMed  CAS  Google Scholar 

  11. Felker GM, Thompson RE, Hare JM, et al.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000, 13:1077–1084.

    Article  Google Scholar 

  12. Sliwa K, Skudicky D, Bergemann A, et al.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000, 35:701–705.

    Article  PubMed  CAS  Google Scholar 

  13. Lampert MB, Winert L, Hibbard J, et al.: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997, 176:189–195. These authors demonstrate the contractile dysfunction in patients with peripartum cardiomyopathy whose heart functions appear to be normal.

    Article  PubMed  CAS  Google Scholar 

  14. Elkayam U, Tummala PP, Rao K, et al.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001, 344:1567–1571.

    Article  PubMed  CAS  Google Scholar 

  15. Cohn JN, Archibald DG, Ziesche S, et al.: Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986, 314:1547–1552.

    Article  PubMed  CAS  Google Scholar 

  16. Cohn JN, Johnson G, Ziesche S, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991, 325:303–353.

    Article  PubMed  CAS  Google Scholar 

  17. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685–691.

    Article  Google Scholar 

  18. Waagstein F, Hjalmarson A, Varnauskas, et al.: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975, 37:1022–1036.

    PubMed  CAS  Google Scholar 

  19. Engelmeier RS, O’Connell JB, Walsh R, et al.: Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 1985, 72:536–546.

    PubMed  CAS  Google Scholar 

  20. Packer M, Antonopoulos GV, Berlin JA, et al.: Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Am Heart J 2001, 141:899–888.

    Article  PubMed  CAS  Google Scholar 

  21. Fowler MB, Vera-Llonch M, Oster G, et al.: Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol 2001, 37:162–1699.

    Article  Google Scholar 

  22. Packer M, Coats AJ, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651–1658.

    Article  PubMed  CAS  Google Scholar 

  23. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091–1100.

    PubMed  CAS  Google Scholar 

  24. Smith SC; Ladenson JH, Mason JW, et al.: Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation 1997, 95:163–168.

    PubMed  CAS  Google Scholar 

  25. Dec GW, Palacios I, Yasuda T, et al.: Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990, 16:97–104.

    Article  PubMed  CAS  Google Scholar 

  26. O’Conell JB, Henkin RE, Robinson JA, et al.: Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984, 70:58–62.

    Google Scholar 

  27. Parrillo JE, Cunnion RE, Epstein SE, et al.: A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989, 321:1061–1068.

    Article  PubMed  CAS  Google Scholar 

  28. Kereiakes DJ, Parmley WW: Myocarditis and cardiomyopathy. Am Heart J 1984, 108:1318–1326.

    Article  PubMed  CAS  Google Scholar 

  29. Jones SR, Herskowitz A, Grover M, et al.: Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 1991, 68:370–376.

    Article  PubMed  CAS  Google Scholar 

  30. Mason JW, O’Connell JB, Herskowitz A, et al.: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333:269–275.

    Article  PubMed  CAS  Google Scholar 

  31. Bozkurt B, Villaneuva FS, Holubkov R, et al.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999, 34:177–180.

    Article  PubMed  CAS  Google Scholar 

  32. Lewis R, Mabie WC, Burlew B: Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy. South Med J 1997, 90:955–958.

    PubMed  CAS  Google Scholar 

  33. Tandler R, Schmid C, Weyand M, et al.: Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardiothorac Surg 1997, 11:394–396.

    Article  PubMed  CAS  Google Scholar 

  34. Johnson MR, Naftel DC, Hobbs RE, et al.: The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group. J Heart Lung Transplant 1997, 16:801–812.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, The Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 536, 21287, Baltimore, MD, USA

    Kenneth L. Baughman MD

Authors
  1. Kenneth L. Baughman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baughman, K.L. Peripartum cardiomyopathy. Curr Treat Options Cardio Med 3, 469–480 (2001). https://doi.org/10.1007/s11936-001-0021-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-001-0021-x

Keywords

Search

Navigation